Sunitinib Malate in Treating Patients With Thyroid Cancer That Did Not Respond to Iodine I 131 and Cannot Be Removed by Surgery

PHASE2CompletedINTERVENTIONAL
Enrollment

63

Participants

Timeline

Start Date

August 29, 2006

Primary Completion Date

December 31, 2016

Study Completion Date

December 10, 2024

Conditions
Differentiated Thyroid Gland CarcinomaRecurrent Thyroid Gland CarcinomaRefractory Thyroid Gland CarcinomaStage III Thyroid Gland Follicular Carcinoma AJCC v7Stage III Thyroid Gland Medullary Carcinoma AJCC v7Stage IV Thyroid Gland Follicular Carcinoma AJCC v7Stage IV Thyroid Gland Medullary Carcinoma AJCC v7Stage IV Thyroid Gland Papillary Carcinoma AJCC v7Stage IVA Thyroid Gland Follicular Carcinoma AJCC v7Stage IVA Thyroid Gland Medullary Carcinoma AJCC v7Stage IVA Thyroid Gland Papillary Carcinoma AJCC v7Stage IVB Thyroid Gland Follicular Carcinoma AJCC v7Stage IVB Thyroid Gland Medullary Carcinoma AJCC v7Stage IVB Thyroid Gland Papillary Carcinoma AJCC v7Stage IVC Thyroid Gland Follicular Carcinoma AJCC v7Stage IVC Thyroid Gland Medullary Carcinoma AJCC v7Stage IVC Thyroid Gland Papillary Carcinoma AJCC v7Thyroid Gland Oncocytic CarcinomaUnresectable Thyroid Gland Carcinoma
Interventions
OTHER

Laboratory Biomarker Analysis

Optional correlative studies

OTHER

Pharmacogenomic Study

Optional correlative studies

DRUG

Sunitinib

Given PO

DRUG

Sunitinib Malate

Given PO

Trial Locations (17)

21201

University of Maryland/Greenebaum Cancer Center, Baltimore

46628

Northern Indiana Cancer Research Consortium, South Bend

46845

Fort Wayne Medical Oncology and Hematology Inc-Parkview, Fort Wayne

48109

University of Michigan Comprehensive Cancer Center, Ann Arbor

49085

Oncology Care Associates PLLC, Saint Joseph

53226

Medical College of Wisconsin, Milwaukee

60153

Loyola University Medical Center, Maywood

60201

NorthShore University HealthSystem-Evanston Hospital, Evanston

60426

Ingalls Memorial Hospital, Harvey

60435

Duly Health and Care Joliet, Joliet

60637

University of Chicago Comprehensive Cancer Center, Chicago

61615

Illinois CancerCare-Peoria, Peoria

62526

Decatur Memorial Hospital, Decatur

62702

Central Illinois Hematology Oncology Center, Springfield

Southern Illinois University School of Medicine, Springfield

63141

Mercy Hospital Saint Louis, St Louis

77030

M D Anderson Cancer Center, Houston

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00381641 - Sunitinib Malate in Treating Patients With Thyroid Cancer That Did Not Respond to Iodine I 131 and Cannot Be Removed by Surgery | Biotech Hunter | Biotech Hunter